Submitted by Anonymous (not verified) on 10 November 2025 - 11:22
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised